Derek W. Gilroy

30.1k total citations · 10 hit papers
143 papers, 17.2k citations indexed

About

Derek W. Gilroy is a scholar working on Immunology, Pharmacology and Molecular Biology. According to data from OpenAlex, Derek W. Gilroy has authored 143 papers receiving a total of 17.2k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Immunology, 44 papers in Pharmacology and 36 papers in Molecular Biology. Recurrent topics in Derek W. Gilroy's work include Inflammatory mediators and NSAID effects (39 papers), Immune Response and Inflammation (33 papers) and Eicosanoids and Hypertension Pharmacology (30 papers). Derek W. Gilroy is often cited by papers focused on Inflammatory mediators and NSAID effects (39 papers), Immune Response and Inflammation (33 papers) and Eicosanoids and Hypertension Pharmacology (30 papers). Derek W. Gilroy collaborates with scholars based in United Kingdom, United States and Ireland. Derek W. Gilroy's co-authors include D. A. Willoughby, Toby Lawrence, Paul Colville‐Nash, James N. Fullerton, Charles N. Serhan, Christopher D. Buckley, Melanie Stables, Mauro Perretti, Adriano G. Rossi and Justine Newson and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Derek W. Gilroy

141 papers receiving 16.9k citations

Hit Papers

Chronic inflammation in t... 1999 2026 2008 2017 2019 1999 2007 2002 2016 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Chronic inflammation in the etiology of disease across the life span
    2019 3.0k citations David Furman, Judith Campisi et al. Nature Medicine profile →
  2. Inducible cyclooxygenase may have anti-inflammatory properties
    1999 1.1k citations Derek W. Gilroy, Paul Colville‐Nash et al. Nature Medicine profile →
  3. Resolution of in flammation: state of the art, definitions and terms
    2007 862 citations Derek W. Gilroy et al. profile →
  4. Anti-inflammatory lipid mediators and insights into the resolution of inflammation
    2002 725 citations D. A. Willoughby, Derek W. Gilroy et al. profile →
  5. Resolution of inflammation: a new therapeutic frontier
    2016 688 citations James N. Fullerton, Derek W. Gilroy profile →
  6. Possible new role for NF-κB in the resolution of inflammation
    2001 643 citations Derek W. Gilroy, Paul Colville‐Nash et al. Nature Medicine profile →
  7. Proresolving Lipid Mediators and Mechanisms in the Resolution of Acute Inflammation
    2014 640 citations Derek W. Gilroy et al. profile →
  8. The fate and lifespan of human monocyte subsets in steady state and systemic inflammation
    2017 639 citations James N. Fullerton, Alexander A. Maini et al. profile →
  9. Inflammatory Resolution: new opportunities for drug discovery
    2004 621 citations Derek W. Gilroy et al. profile →
  10. A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis
    2021 194 citations Derek W. Gilroy et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Derek W. Gilroy 5.3k 5.1k 2.4k 2.1k 2.0k 143 17.2k
Daniel Hwang 3.9k 0.8× 6.3k 1.2× 2.0k 0.8× 2.5k 1.2× 2.8k 1.4× 131 15.4k
Colin Funk 3.7k 0.7× 6.8k 1.3× 4.7k 1.9× 1.7k 0.8× 1.2k 0.6× 183 17.6k
Thomas M. Coffman 2.4k 0.5× 6.4k 1.3× 3.7k 1.5× 1.8k 0.8× 1.1k 0.5× 253 20.3k
William F. Stenson 2.6k 0.5× 3.4k 0.7× 3.9k 1.6× 1.7k 0.8× 1.5k 0.8× 174 14.4k
Toru Kita 7.0k 1.3× 9.3k 1.8× 1.7k 0.7× 2.6k 1.3× 2.5k 1.2× 480 28.4k
Bruce D. Levy 4.1k 0.8× 3.0k 0.6× 1.3k 0.5× 3.8k 1.8× 1.3k 0.6× 212 13.2k
Tomasz J. Guzik 4.3k 0.8× 4.0k 0.8× 932 0.4× 3.0k 1.4× 2.2k 1.1× 241 19.8k
Wulf Dröge 4.3k 0.8× 10.3k 2.0× 953 0.4× 1.7k 0.8× 1.7k 0.9× 173 22.2k
Angelika Bierhaus 4.5k 0.9× 6.2k 1.2× 779 0.3× 1.2k 0.6× 2.4k 1.2× 247 22.7k
Rosanna Di Paola 2.4k 0.5× 5.2k 1.0× 2.3k 0.9× 820 0.4× 1.1k 0.5× 402 15.3k

Countries citing papers authored by Derek W. Gilroy

Since Specialization
Citations

This map shows the geographic impact of Derek W. Gilroy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derek W. Gilroy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derek W. Gilroy more than expected).

Fields of papers citing papers by Derek W. Gilroy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Derek W. Gilroy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derek W. Gilroy. The network helps show where Derek W. Gilroy may publish in the future.

Co-authorship network of co-authors of Derek W. Gilroy

This figure shows the co-authorship network connecting the top 25 collaborators of Derek W. Gilroy. A scholar is included among the top collaborators of Derek W. Gilroy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Derek W. Gilroy. Derek W. Gilroy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Snow, Timothy Arthur Chandos, et al.. (2026). Challenges of monocyte HLA-DR targeted immunomodulation in sepsis—a prospective observational cohort study. Frontiers in Immunology. 16. 1709289–1709289.
2.
Feehan, Karen, Hannah E. Bridgewater, Roel P. H. De Maeyer, et al.. (2024). Post-resolution macrophages shape long-term tissue immunity and integrity in a mouse model of pneumococcal pneumonia. Nature Communications. 15(1). 4326–4326. 6 indexed citations
3.
Collins, George, Saroj Jayasinghe, David M. Lowe, et al.. (2024). A new model measuring bacterial phagocytosis and phagolysosomal oxidation in humans using the intradermal injection of methylene blue–labeled Escherichia coli. Journal of Leukocyte Biology. 117(2). 1 indexed citations
4.
Homer, Natalie, Ruth Andrew, & Derek W. Gilroy. (2024). Review of methodology and re‐analysis of lipidomic data focusing on specialised pro‐resolution lipid mediators (SPMs) in a human model of resolving inflammation. International Journal of Experimental Pathology. 106(1). e12523–e12523. 1 indexed citations
5.
Caxaria, Sara, B.L. Thomas, Francesco Dell’Accio, et al.. (2023). Neutrophils infiltrate sensory ganglia and mediate chronic widespread pain in fibromyalgia. Proceedings of the National Academy of Sciences. 120(17). e2211631120–e2211631120. 46 indexed citations
6.
Chrysikou, E, et al.. (2022). Home-built environment interventions and inflammation biomarkers: a systematic review and meta-analysis protocol. BJGP Open. 6(4). BJGPO.2022.0104–BJGPO.2022.0104. 3 indexed citations
7.
Maeyer, Roel P. H. De, Olivia V. Bracken, Oliver Devine, et al.. (2020). Blocking elevated p38 MAPK restores efferocytosis and inflammatory resolution in the elderly. Nature Immunology. 21(6). 615–625. 128 indexed citations
8.
Furman, David, Judith Campisi, Eric Verdin, et al.. (2019). Chronic inflammation in the etiology of disease across the life span. Nature Medicine. 25(12). 1822–1832. 3020 indexed citations breakdown →
9.
Gilroy, Derek W. & David Bishop‐Bailey. (2019). Lipid mediators in immune regulation and resolution. British Journal of Pharmacology. 176(8). 1009–1023. 65 indexed citations
10.
Motwani, Madhur P., et al.. (2017). Prolonged immune alteration following resolution of acute inflammation in humans. PLoS ONE. 12(10). e0186964–e0186964. 31 indexed citations
11.
Fullerton, James N., et al.. (2016). Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation. Journal of Visualized Experiments. 6 indexed citations
12.
Gilroy, Derek W., Matthew L. Edin, Roel P. H. De Maeyer, et al.. (2016). CYP450-derived oxylipins mediate inflammatory resolution. Proceedings of the National Academy of Sciences. 113(23). E3240–9. 118 indexed citations
13.
Scotland, Ramona S., Melanie Stables, Shimona Madalli, Peter H. Watson, & Derek W. Gilroy. (2011). Sex differences in resident immune cell phenotype underlie more efficient acute inflammatory responses in female mice. Blood. 118(22). 5918–5927. 235 indexed citations
14.
Newson, Justine, et al.. (2009). A New Strategy for the Identification of Novel Molecules with Targeted Proresolution of Inflammation Properties. The Journal of Immunology. 184(3). 1516–1525. 84 indexed citations
15.
Rajakariar, Ravindra, Justine Newson, Edwin K. Jackson, et al.. (2009). Nonresolving Inflammation in gp91 phox −/− Mice, a Model of Human Chronic Granulomatous Disease, Has Lower Adenosine and Cyclic Adenosine 5′-Monophosphate. The Journal of Immunology. 182(5). 3262–3269. 24 indexed citations
16.
Byström, Jonas, Ian Evans, Justine Newson, et al.. (2008). Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP. Blood. 112(10). 4117–4127. 259 indexed citations
17.
Trivedi, Seema, Justine Newson, Ravindra Rajakariar, et al.. (2006). Essential role for hematopoietic prostaglandin D2 synthase in the control of delayed type hypersensitivity. Proceedings of the National Academy of Sciences. 103(13). 5179–5184. 109 indexed citations
18.
Gilroy, Derek W., John F. Kerry, John F. Kerry, et al.. (2003). Evaluation of surimi, fat and water content in a low/no added pork sausage formulation using response surface methodology. Meat Science. 66(3). 689–701. 84 indexed citations
19.
Paul‐Clark, Mark J., Derek W. Gilroy, Dean Willis, D. A. Willoughby, & Annette Tomlinson. (2001). Nitric Oxide Synthase Inhibitors Have Opposite Effects on Acute Inflammation Depending on Their Route of Administration. The Journal of Immunology. 166(2). 1169–1177. 65 indexed citations
20.
Kerry, Joe P., Derek W. Gilroy, Maura Hiney, Rosie Coyne, & Pete Smith. (1995). The effects of harrowing on oxytetracycline resistance in marine sediment micro-organisms beneath a salmon farm. Bulletin of the European Association of Fish Pathologists. 15(5). 172–175. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Hwang Breakdown of academic impact, for papers by Colin Funk Breakdown of academic impact, for papers by Thomas M. Coffman Breakdown of academic impact, for papers by William F. Stenson Breakdown of academic impact, for papers by Toru Kita Breakdown of academic impact, for papers by Bruce D. Levy Breakdown of academic impact, for papers by Tomasz J. Guzik Breakdown of academic impact, for papers by Wulf Dröge Breakdown of academic impact, for papers by Angelika Bierhaus Breakdown of academic impact, for papers by Rosanna Di Paola
Rankless by CCL
2026